Predominance of HA-222D/G Polymorphism in Influenza A(H1N1)pdm09 Viruses Associated with Fatal and Severe Outcomes Recently Circulating in Germany

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wedde, Marianne ^a   Wählisch, Stephanie ^a   Wolff, Thorsten ^a   Schweiger, Brunhilde ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; OSELTAMIVIR; TYROSINE; VALINE; VIRUS HEMAGGLUTININ; VIRUS RECEPTOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EVOLUTIONARY ADAPTATION; FATALITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERMANY; HA 222D GENE; HA 222G GENE; HUMAN; HUMAN TISSUE; INFANT; INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PRESCHOOL CHILD; PYROSEQUENCING; SCHOOL CHILD; SEASONAL VARIATION; VIRAL TROPISM; VIRUS GENE; VIRUS MUTANT; WILD TYPE;

GERMANY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84874535546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057059     Document Type: Article

References (39)

1. Novel Swine-Origin Influenza AVIT (2009) Dawood FS, Jain S, Finelli L, Shaw MW, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
2. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
3. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12: 687-695.
4. Buda S, Schweiger B, Buchholz U, Köpke K, Luchtenberg M, et al. (2011) Influenza-Wochenbericht. Kalenderwoche 15 (09.04. bis 15.04.2011). Arbeitsgemeinschaft Influenza Robert Koch-Institut, Berlin Available: http://influenza.rki.de/Wochenberichte/2010_2011/2011-15.pdf.
5. Kilander A, Rykkvin R, Dudman SG, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15.
6. Kilander A, Rykkvin R, Dudman SG, Hungnes O, (2010) Author's reply: Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15.
7. Yang H, Carney P, Stevens J, (2010) Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr 2: RRN1152.
8. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One 5: e8553.
9. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
10. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436.
11. Glaser L, Stevens J, Zamarin D, Wilson IA, Garcia-Sastre A, et al. (2005) A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79: 11533-11536.
12. Reid AH, Fanning TG, Hultin JV, Taubenberger JK, (1999) Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 96: 1651-1656.
13. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, et al. (2004) Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303: 1866-1870.
14. Worl Health Organization (2009) Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. Available: http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html. Accessed 2012 Jun 25.
15. Schulze M, Nitsche A, Schweiger B, Biere B, (2010) Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One 5: e9966.
16. Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, et al. (2010) Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15.
17. Miller RR, MacLean AR, Gunson RN, Carman WF, (2010) Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 15.
18. European Centre for Disease Prevention and Control (2009) Pandemic influenza A(H1N1) virus mutations reported to be associated with severe disease. Available: http://ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f-77d4-4ad8-b6d6-bf0f23083f30&ID=695. Accessed 2012 Jun 25.
19. World Health Organization (2010) Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 85: 21-22.
20. Puzelli S, Facchini M, De Marco MA, Palmieri A, Spagnolo D, et al. (2010) Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill 15.
21. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, et al. (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355: 1143-1155.
22. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, et al. (2010) Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 84: 12069-12074.
23. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, et al. (2010) Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 84: 11802-11813.
24. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, et al. (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315: 655-659.
25. Chen H, Wen X, To KK, Wang P, Tse H, et al. (2010) Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 201: 1517-1521.
26. Wang B, Dwyer DE, Soedjono M, Shi H, Matlho K, et al. (2011) Evidence of the circulation of pandemic influenza (H1N1) 2009 with D222D/G/N/S hemagglutinin polymorphisms during the first wave of the 2009 influenza pandemic. J Clin Virol 52: 304-306.
27. Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, et al. (2011) Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 16.
28. Baldanti F, Campanini G, Piralla A, Rovida F, Braschi A, et al. (2011) Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicentre study. Clin Microbiol Infect 17: 1166-1169.
29. Baldanti F, Zanetti A, (2011) Letter to the editor. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 16:/19774 author reply pii/19773.
30. Weinheimer V, Becher A, Tönnies M, Holland G, Knepper J, et al. (2012) Iinfluenza A viruses target type II pneumocytes in the human lung. J Infect Dis in press.
31. Belser JA, Jayaraman A, Raman R, Pappas C, Zeng H, et al. (2011) Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One 6: e25091.
32. Berdal JE, Mollnes TE, Waehre T, Olstad OK, Halvorsen B, et al. (2011) Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect 63: 308-316.
33. Tse H, To KK, Wen X, Chen H, Chan KH, et al. (2011) Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One 6: e22534.
34. Bratincsak A, El-Said HG, Bradley JS, Shayan K, Grossfeld PD, et al. (2010) Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 55: 928-929.
35. Khouzam RN, Parizianu C, Hafiz AM, Chawla S, Schwartz R, (2011) Fulminant myocarditis associated with novel H1N1 influenza A. Heart Lung 40: 566-568.
36. Morera D, Mackenzie SA, (2011) Is there a direct role for erythrocytes in the immune response? Vet Res 42: 89.
37. Cornacoff JB, Hebert LA, Smead WL, VanAman ME, Birmingham DJ, et al. (1983) Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 71: 236-247.
38. Powers JH, Buster BL, Reist CJ, Martin E, Bridges M, et al. (1995) Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1. Infect Immun 63: 1329-1335.
39. Levine M, Sheu TG, Gubareva LV, Mishin VP, (2011) Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing. J Clin Microbiol 49: 1307-1312.